Muhammad Imam, MD
Dr. Imam is an oncologist and hematologist for Florida Cancer Specialists & Research Institute in Winter Park.
Dr. Muhammad “Hassan” Imam was born in Santa Barbara, California, but grew up most of his life in Deltona, Florida. He was valedictorian of his high school and graduated Summa Cum Laude from the University of Miami. Dr. Imam joined Florida Cancer Specialists after completing his Fellowship in Hematology/ Oncology at the University of Texas Southwestern in Dallas. He actively participates in clinical trials research. His work has been published in several industry journals, During, including Leukemia & Lymphoma and the prestigious American Journal of Clinical Oncology. He is Board-certified in Medical Oncology, Hematology and Internal Medicine.
Dr. Imam describes being an oncologist as a special honor. He values the opportunity to assist his patients through their cancer journey, taking advantage of all the resources and forms of treatment to enable them to find relief and live their lives to the fullest.
In addition to being a husband and father of two children, Dr. Imam is a co-founder of Project Downtown, a non-profit organization that serves the homeless and needy populations in over 20 cities nationwide. Project Downtown began several years ago as an informal initiative by a group of students at the University of Miami who were determined to make a difference in the lives of these individuals.
- Medical Oncology
- University of South Florida College of Medicine- Tampa, FL
- Emory University – Atlanta, GA
- Hematology/Medical Oncology
- University of Texas Southwestern – Dallas, TX
- UTSW St. Paul University Hospital
- Parkland Memorial Hospital
- UTSW Zale-Lipshy Hospital
- Internal Medicine, Medical Oncology and Hematology
Honors & Achievements
- Emory Internal Medicine Residency Award for Excellence in Primary Care
- Hematology PCR, Lecturer for Malignant Hematology
- American Society of Clinical Oncology
- American Society of Hematology
- Founder of non-profit organization: Project Downtown
Metastatic Breast Cancer Awareness Day: Assessing the Role of ADCs
Dr. Muhammad Imam, FCS Medical Oncologist & Hematologist, for Metastatic Breast Cancer Awareness Day (October 13), wrote an article discussing the role of antibody-drug conjugates (ADCs) – medicines specifically designed to deliver chemotherapy to targeted cancer cells. His article was featured by Targeted Oncology.